RiceBran Technologies And Roku On The List Of Winners And Losers Of Monday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are RiceBran Technologies, ParkerVision, and PRA Group.

Rank Financial Asset Price Change Updated (EST)
1 RiceBran Technologies (RIBT) 0.15 18.23% 2024-02-19 13:55:24
2 ParkerVision (PRKR) 0.20 16% 2024-02-19 06:23:06
3 PRA Group (PRAA) 28.00 14.24% 2024-02-19 05:12:05
4 Viking Therapeutics (VKTX) 36.20 13.66% 2024-02-19 10:17:55
5 Ocular Therapeutix (OCUL) 7.58 10.5% 2024-02-18 19:42:06
6 Coinbase (COIN) 180.31 8.84% 2024-02-19 10:01:53
7 uniQure N.V. (QURE) 5.85 6.75% 2024-02-19 11:08:05
8 Inovio Pharmaceuticals (INO) 7.93 6.59% 2024-02-19 10:13:12
9 Canopy Growth (CGC) 3.82 6.41% 2024-02-19 10:23:39
10 Applied Materials (AMAT) 199.57 6.35% 2024-02-19 10:10:34

The three biggest losers today are Roku, Dropbox, and Super Micro Computer.

Rank Financial Asset Price Change Updated (EST)
1 Roku (ROKU) 72.00 -23.81% 2024-02-19 10:17:19
2 Dropbox (DBX) 25.08 -22.93% 2024-02-19 10:51:36
3 Super Micro Computer (SMCI) 803.32 -19.99% 2024-02-19 10:14:50
4 Yelp (YELP) 38.02 -14.35% 2024-02-19 10:01:05
5 Pacific Biosciences of California (PACB) 5.74 -13.94% 2024-02-19 10:14:14
6 Sabre Corporation (SABR) 2.96 -13.45% 2024-02-19 10:14:39
7 Gevo (GEVO) 0.89 -10.14% 2024-02-19 10:12:42
8 Redfin (RDFN) 7.19 -8.76% 2024-02-19 10:17:14
9 Adobe (ADBE) 546.66 -7.41% 2024-02-19 10:10:19
10 Perma-Fix Environmental Services (PESI) 8.06 -7.14% 2024-02-19 03:07:05

Winners today

1. RiceBran Technologies (RIBT) – 18.23%

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

NASDAQ ended the session with RiceBran Technologies rising 18.23% to $0.15 on Monday, after three sequential sessions in a row of gains. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, RiceBran Technologies has a trailing twelve months EPS of $-1.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.59%.

More news about RiceBran Technologies.

2. ParkerVision (PRKR) – 16%

ParkerVision, Inc. develops and markets radio frequency technologies and integrated circuits for use in wireless communication products. The company was incorporated in 1989 and is headquartered in Jacksonville, Florida.

NASDAQ ended the session with ParkerVision jumping 16% to $0.20 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, ParkerVision has a trailing twelve months EPS of $0.02.

PE Ratio

ParkerVision has a trailing twelve months price to earnings ratio of 10.15. Meaning, the purchaser of the share is investing $10.15 for every dollar of annual earnings.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ParkerVision’s EBITDA is -2.21.

Moving Average

ParkerVision’s worth is way higher than its 50-day moving average of $0.17 and way above its 200-day moving average of $0.12.

More news about ParkerVision.

3. PRA Group (PRAA) – 14.24%

PRA Group, Inc., a financial and business services company, engages in the purchase, collection, and management of portfolios of nonperforming loans in the Americas, Australia, and Europe. It is involved in the purchase of accounts that are primarily the unpaid obligations of individuals owed to credit originators, which include banks and other types of consumer, retail, and auto finance companies. The company also acquires nonperforming loans, including Visa and MasterCard credit cards, private label and other credit cards, installment loans, lines of credit, deficiency balances of various types, legal judgments, and trade payables from banks, credit unions, consumer finance companies, retailers, utilities, automobile finance companies, and other credit originators. In addition, it provides fee-based services on class action claims recoveries and by servicing consumer bankruptcy accounts. The company was formerly known as Portfolio Recovery Associates, Inc. and changed its name to PRA Group, Inc. in October 2014. PRA Group, Inc. was incorporated in 1996 and is headquartered in Norfolk, Virginia.

NASDAQ ended the session with PRA Group rising 14.24% to $28.00 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, PRA Group has a trailing twelve months EPS of $-2.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.28%.

Yearly Top and Bottom Value

PRA Group’s stock is valued at $28.00 at 16:32 EST, way under its 52-week high of $43.34 and way above its 52-week low of $11.85.

Moving Average

PRA Group’s worth is way higher than its 50-day moving average of $23.77 and way above its 200-day moving average of $21.07.

More news about PRA Group.

4. Viking Therapeutics (VKTX) – 13.66%

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Viking Therapeutics rising 13.66% to $36.20 on Monday, following the last session’s upward trend. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.91.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.79%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 8% and a negative 47.4%, respectively.

Volume

Today’s last reported volume for Viking Therapeutics is 9397030 which is 201.64% above its average volume of 3115290.

More news about Viking Therapeutics.

5. Ocular Therapeutix (OCUL) – 10.5%

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with Ocular Therapeutix rising 10.5% to $7.58 on Monday, after three sequential sessions in a row of gains. NASDAQ fell 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Ocular Therapeutix has a trailing twelve months EPS of $-1.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -247.99%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 26%, now sitting on 57.72M for the twelve trailing months.

Yearly Top and Bottom Value

Ocular Therapeutix’s stock is valued at $7.58 at 16:32 EST, below its 52-week high of $7.96 and way above its 52-week low of $2.00.

More news about Ocular Therapeutix.

6. Coinbase (COIN) – 8.84%

Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

NASDAQ ended the session with Coinbase jumping 8.84% to $180.31 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Coinbase has a trailing twelve months EPS of $0.38.

PE Ratio

Coinbase has a trailing twelve months price to earnings ratio of 474.5. Meaning, the purchaser of the share is investing $474.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.74%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coinbase’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Coinbase is 33233300 which is 135.5% above its average volume of 14111600.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Coinbase’s EBITDA is 179.31.

Moving Average

Coinbase’s value is way above its 50-day moving average of $131.33 and way higher than its 200-day moving average of $87.19.

More news about Coinbase.

7. uniQure N.V. (QURE) – 6.75%

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

NASDAQ ended the session with uniQure N.V. jumping 6.75% to $5.85 on Monday, after two sequential sessions in a row of gains. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, uniQure N.V. has a trailing twelve months EPS of $-4.79.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.23%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

uniQure N.V.’s EBITDA is 2.36.

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.9%, now sitting on 111.9M for the twelve trailing months.

Yearly Top and Bottom Value

uniQure N.V.’s stock is valued at $5.85 at 16:32 EST, way below its 52-week high of $22.48 and way above its 52-week low of $5.19.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 1135.7% and positive 23.3% for the next.

More news about uniQure N.V..

8. Inovio Pharmaceuticals (INO) – 6.59%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals jumping 6.59% to $7.93 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-7.56.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.3%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Inovio Pharmaceuticals’s EBITDA is 1.84.

More news about Inovio Pharmaceuticals.

9. Canopy Growth (CGC) – 6.41%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth jumping 6.41% to $3.82 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

Yearly Top and Bottom Value

Canopy Growth’s stock is valued at $3.82 at 16:32 EST, way under its 52-week high of $24.70 and way above its 52-week low of $3.30.

More news about Canopy Growth.

10. Applied Materials (AMAT) – 6.35%

Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits. This segment also offers various technologies, including epitaxy, ion implantation, oxidation/nitridation, rapid thermal processing, physical vapor deposition, chemical vapor deposition, chemical mechanical planarization, electrochemical deposition, atomic layer deposition, etching, and selective deposition and removal, as well as metrology and inspection tools. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity comprising spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays; organic light-emitting diodes; and other display technologies for TVs, monitors, laptops, personal computers, electronic tablets, smart phones, and other consumer-oriented devices. It operates in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company was incorporated in 1967 and is headquartered in Santa Clara, California.

NASDAQ ended the session with Applied Materials rising 6.35% to $199.57 on Monday while NASDAQ fell 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Applied Materials has a trailing twelve months EPS of $8.5.

PE Ratio

Applied Materials has a trailing twelve months price to earnings ratio of 23.48. Meaning, the purchaser of the share is investing $23.48 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.41%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 1.7% and 5%, respectively.

Moving Average

Applied Materials’s value is way higher than its 50-day moving average of $163.57 and way higher than its 200-day moving average of $145.73.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 26.49B for the twelve trailing months.

Volatility

Applied Materials’s last week, last month’s, and last quarter’s current intraday variation average was 1.88%, 0.89%, and 1.73%.

Applied Materials’s highest amplitude of average volatility was 3.33% (last week), 2.09% (last month), and 1.73% (last quarter).

More news about Applied Materials.

Losers Today

1. Roku (ROKU) – -23.81%

Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Devices. Its streaming platform allows users to find and access TV shows, movies, news, sports, and others. The company also provides digital advertising and related services, including the demand-side ad platform and content distribution services, such as subscription and transaction revenue shares; media and entertainment promotional spending services; premium subscriptions services; video and display advertising services; and sells branded channel buttons on remote controls of streaming device. In addition, it offers billing services; and brand sponsorship and promotions, as well as manufactures, sells, and licenses smart TVs under the Roku TV name. Further, the company provides streaming players, audio products, and smart home products and accessories under the Roku brand name. It offers its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Mexico, Canada, the United Kingdom, Brazil, and Germany. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.

NASDAQ ended the session with Roku dropping 23.81% to $72.00 on Monday, following the last session’s downward trend. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Roku has a trailing twelve months EPS of $-5.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.54%.

More news about Roku.

2. Dropbox (DBX) – -22.93%

Dropbox, Inc. provides a content collaboration platform worldwide. The company's platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

NASDAQ ended the session with Dropbox falling 22.93% to $25.08 on Monday while NASDAQ slid 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Dropbox has a trailing twelve months EPS of $1.31.

PE Ratio

Dropbox has a trailing twelve months price to earnings ratio of 19.15. Meaning, the purchaser of the share is investing $19.15 for every dollar of annual earnings.

More news about Dropbox.

3. Super Micro Computer (SMCI) – -19.99%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer sliding 19.99% to $803.32 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $12.77.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 62.91. Meaning, the purchaser of the share is investing $62.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.92%.

Moving Average

Super Micro Computer’s worth is way above its 50-day moving average of $436.53 and way higher than its 200-day moving average of $300.73.

More news about Super Micro Computer.

4. Yelp (YELP) – -14.35%

Yelp Inc. operates a platform that connects consumers with local businesses in the United States and internationally. The company's platform covers various local business categories, including restaurants, shopping, beauty and fitness, health, and other categories, as well as home, local, auto, professional, pets, events, real estate, and financial services. It provides free and paid advertising products to businesses, which include cost-per-click search advertising and multi-location Ad products, as well as enables businesses to deliver targeted search advertising to local audiences; and business listing page products. The company also offers other services comprising Yelp Guest Manager, a subscription-based suite of front-of-house management tools for restaurants, nightlife and certain other venues, which include online reservations, a waitlist management solution that allows consumers to check wait times and join waitlists remotely as well as through hostless kiosks, and seating and server rotation management tools; Yelp Knowledge program that offers business owners local analytics and insights through access to its historical data and other proprietary content; and Yelp Fusion, which offers free and paid access to content and data for consumer-facing enterprise use through publicly available APIs. In addition, it provides content licensing, as well as allows third-party data providers to update and manage business listing information on behalf of businesses. Further, the company offers its products directly through its sales force; indirectly through partners; and online through its website and business app, as well as non-advertising partner arrangements. It has partnership with Grubhub for providing consumers with a service to place food orders for pickup and delivery. The company was incorporated in 2004 and is headquartered in San Francisco, California.

NYSE ended the session with Yelp falling 14.35% to $38.02 on Monday while NYSE fell 0.15% to $17,409.30.

Earnings Per Share

As for profitability, Yelp has a trailing twelve months EPS of $1.35.

PE Ratio

Yelp has a trailing twelve months price to earnings ratio of 28.16. Meaning, the purchaser of the share is investing $28.16 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.76%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Yelp’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

Yelp’s stock is valued at $38.02 at 16:32 EST, way under its 52-week high of $48.99 and way higher than its 52-week low of $26.53.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 1.3B for the twelve trailing months.

More news about Yelp.

5. Pacific Biosciences of California (PACB) – -13.94%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California sliding 13.94% to $5.74 on Monday, following the last session’s downward trend. NASDAQ fell 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.53%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Pacific Biosciences of California’s EBITDA is -32.1.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pacific Biosciences of California’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.74 at 16:32 EST, way under its 52-week high of $14.55 and above its 52-week low of $5.68.

Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $7.87 and way below its 200-day moving average of $9.96.

More news about Pacific Biosciences of California.

6. Sabre Corporation (SABR) – -13.45%

Sabre Corporation, together with its subsidiaries, operates as software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates through two segments: Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. Its Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.

NASDAQ ended the session with Sabre Corporation falling 13.45% to $2.96 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.56.

Moving Average

Sabre Corporation’s value is way below its 50-day moving average of $4.22 and way below its 200-day moving average of $4.04.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 122.2% and 117.6%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 2.91B for the twelve trailing months.

More news about Sabre Corporation.

7. Gevo (GEVO) – -10.14%

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo falling 10.14% to $0.89 on Monday, following the last session’s downward trend. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.22%.

Volatility

Gevo’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.36%, a positive 0.15%, and a positive 4.36%.

Gevo’s highest amplitude of average volatility was 7.77% (last week), 5.18% (last month), and 4.36% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 1365.4%, now sitting on 13.37M for the twelve trailing months.

Volume

Today’s last reported volume for Gevo is 8762430 which is 44.24% above its average volume of 6074580.

More news about Gevo.

8. Redfin (RDFN) – -8.76%

Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Redfin sliding 8.76% to $7.19 on Monday, following the last session’s downward trend. NASDAQ fell 0.82% to $15,775.65, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Redfin has a trailing twelve months EPS of $-1.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -209.25%.

More news about Redfin.

9. Adobe (ADBE) – -7.41%

Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide. It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to create, publish, and promote content; and Document Cloud, a unified cloud-based document services platform. Its flagship product is Creative Cloud, a subscription service that allows members to access its creative products. This segment serves content creators, students, workers, marketers, educators, enthusiasts, and communicators. The Digital Experience segment provides an integrated platform and set of applications and services that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce. This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite. The Publishing and Advertising segment offers products and services, such as e-learning solutions, technical document publishing, web conferencing, document and forms platform, web application development, and high-end printing, as well as Advertising Cloud offerings. It also provides consulting, technical support, and learning services. The company offers its products and services directly to enterprise customers through its sales force and local field offices, as well as to end users through app stores and through its website at adobe.com. It also distributes products and services through distributors, value-added resellers, systems integrators, software vendors and developers, retailers, and original equipment manufacturers. The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018. Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.

NASDAQ ended the session with Adobe falling 7.41% to $546.66 on Monday while NASDAQ fell 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Adobe has a trailing twelve months EPS of $11.81.

PE Ratio

Adobe has a trailing twelve months price to earnings ratio of 46.29. Meaning, the purchaser of the share is investing $46.29 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.51%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Adobe’s EBITDA is 12.54.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Adobe’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 15.3% and 12%, respectively.

Yearly Top and Bottom Value

Adobe’s stock is valued at $546.66 at 16:32 EST, way under its 52-week high of $638.25 and way higher than its 52-week low of $318.60.

More news about Adobe.

10. Perma-Fix Environmental Services (PESI) – -7.14%

Perma-Fix Environmental Services, Inc., through its subsidiaries, operates as an environmental and technology know-how company in the United States. It operates in three segments: Treatment, Services, and Medical. The Treatment segment offers nuclear, low-level radioactive, mixed waste, hazardous and non-hazardous waste treatment, and processing and disposal services through treatment and storage facilities. This segment is also involved in the research and development activities to identify, develop, and implement waste processing techniques for problematic waste streams. The Services segment provides technical services, including professional radiological measurement and site survey of government and commercial installations; integrated occupational safety and health services; and consulting, engineering, project and waste management, environmental, decontamination and decommissioning (D&D) field, technical, on-site waste management services, and management personnel and services. This segment also offers nuclear services, including technology-based services comprising engineering, D&D, specialty, construction, logistics, transportation, processing, and disposal; offers remediation of nuclear licensed and federal facilities, as well as cleanup of nuclear legacy sites; and owns an equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources health physics, industrial hygiene, and customized nuclear, environmental, and occupational safety and health instrumentation. The Medical segment is involved in the research and development of medical isotope production technology. The company provides its services to research institutions, commercial companies, public utilities, and governmental agencies through direct sales to customers or through intermediaries. Perma-Fix Environmental Services, Inc. was incorporated in 1990 and is based in Atlanta, Georgia.

NASDAQ ended the session with Perma-Fix Environmental Services dropping 7.14% to $8.06 on Monday while NASDAQ dropped 0.82% to $15,775.65.

Earnings Per Share

As for profitability, Perma-Fix Environmental Services has a trailing twelve months EPS of $-0.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.78%.

Volume

Today’s last reported volume for Perma-Fix Environmental Services is 42811 which is 8.76% above its average volume of 39360.

Yearly Top and Bottom Value

Perma-Fix Environmental Services’s stock is valued at $8.06 at 16:32 EST, way under its 52-week high of $13.87 and way above its 52-week low of $6.40.

More news about Perma-Fix Environmental Services.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *